Due to possible for really serious adverse reactions in infants from mitoxantrone, breastfeeding ought to be discontinued before beginning treatment. Clients who experienced an incomplete antileukemic response obtained a next induction class in which mitoxantrone or daunorubicin was administered for two times and cytarabine for five times using the similar https://henryw752lrv5.muzwiki.com/user